CAS 1278466-20-8

Lampalizumab

CAS : 1278466-20-8

Lampalizumab (RG 7417) is a humanized monoclonal antibody targeting Factor D, which can be used in cardiovascular disease research.

Degré de pureté : >95%

Couleur et forme : Liquid

Masse moléculaire : 143.8 kDa

Ref: TM-T76814

Lampalizumab

CAS : 1278466-20-8

A humanised monoclonal antibody targeting complement Factor D.

Ref: 3D-CLA1305